Abstract:Purpose of review: With the advancement of computational approaches and abundance of biomedical data, a broad range of neurodegenerative disease models have been developed. In this review, we argue that computational models can be both relevant and useful in neurodegenerative disease research and although the current established models have limitations in clinical practice, artificial intelligence has the potential to overcome deficiencies encountered by these models, which in turn can improve our understanding of disease. Recent findings: In recent years, diverse computational approaches have been used to shed light on different aspects of neurodegenerative disease models. For example, linear and nonlinear mixed models, self-modeling regression, differential equation models, and event-based models have been applied to provide a better understanding of disease progression patterns and biomarker trajectories. Additionally, the Cox-regression technique, Bayesian network models, and deep-learning-based approaches have been used to predict the probability of future incidence of disease, whereas nonnegative matrix factorization, nonhierarchical cluster analysis, hierarchical agglomerative clustering, and deep-learning-based approaches have been employed to stratify patients based on their disease subtypes. Furthermore, the interpretation of neurodegenerative disease data is possible through knowledge-based models which use prior knowledge to complement data-driven analyses. These knowledge-based models can include pathway-centric approaches to establish pathways perturbed in a given condition, as well as disease-specific knowledge maps, which elucidate the mechanisms involved in a given disease. Collectively, these established models have revealed high granular details and insights into neurodegenerative disease models. Summary: In conjunction with increasingly advanced computational approaches, a wide spectrum of neurodegenerative disease models, which can be broadly categorized into data-driven and knowledge-driven, have been developed. We review the state of the art data and knowledge-driven models and discuss the necessary steps which are vital to bring them into clinical application.

Computational Neurology: Computational Modeling Approaches in Dementia

Comprehensive computational analysis approach for Alzheimer's disease

Advances in Computational Biology for Diagnosing Neurodegenerative Diseases: A Comprehensive Review

Artificial Intelligence in The Management of Neurodegenerative Disorders

Neuroimaging and Machine Learning for Dementia Diagnosis: Recent Advancements and Future Prospects.

Beyond the usual suspects: multi-factorial computational models in the search for neurodegenerative disease mechanisms

Multimodal deep learning for Alzheimer’s disease dementia assessment

A computational model of Alzheimer's disease at the nano, micro, and macroscales

Comprehensive overview of Alzheimer's disease utilizing Machine Learning approaches

Data science in neurodegenerative disease: its capabilities, limitations, and perspectives

Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer's Disease

Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease

Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer’s Disease and Reconstruction of Relevant Biological Mechanisms

Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review

Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review

Artificial intelligence for dementia—Applied models and digital health

Addressing the Gaps in Early Dementia Detection: A Path Towards Enhanced Diagnostic Models through Machine Learning

A Review on the Use of Modern Computational Methods in Alzheimer's Disease-Detection and Prediction

Review of Deep Learning Techniques for Neurological Disorders Detection

Artificial Intelligence for Dementia Research Methods Optimization

Advances in neuroimaging to support translational medicine in dementia